<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We analyzed 17 B-cell lineages cloned from two patients with <z:e sem="disease" ids="C0021345" disease_type="Disease or Syndrome" abbrv="">infectious mononucleosis</z:e> and found that different B-cell lineages exhibited notable variation in the length of the fused Epstein-Barr virus (EBV) terminal region on intracellular EBV episomes </plain></SENT>
<SENT sid="1" pm="."><plain>EBV termini in different B-cell clones from the same person differed by as many as 15 to 20 reiterations of the ca </plain></SENT>
<SENT sid="2" pm="."><plain>500-base-pair terminal repeat sequence </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, analysis of seven B-cell lineages cloned from a patient with a fatal, oligoclonal <z:hpo ids='HP_0002665'>lymphoma</z:hpo> revealed that three of the cell clones had the same-sized EBV terminal region </plain></SENT>
<SENT sid="4" pm="."><plain>These three clones had previously been shown, by immunoglobulin gene analysis, to be metastatic daughter cells descended from a common progenitor </plain></SENT>
<SENT sid="5" pm="."><plain>Similarity of the EBV terminal regions in the three daughter clones suggested that EBV infected the progenitor cell before proliferation and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Individual, EBV-infected cells from a single individual showed sufficient <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in their EBV termini to allow use of terminal fragment size as a clonal marker in studies addressing the contribution of EBV to the clonal pathogenesis of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with which this virus has been associated </plain></SENT>
</text></document>